The apparent divergence of CSF-1R-dependence amongst macrophages in the endometrium may provide a novel strategy for targeting endometrial macrophage subsets which may be a beneficial therapeutic target in the treatment of menstrual disorders. The gene discussed is CSF1R; the disease is Menstrual disorder.